Loading...

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injections of the missing FVIII often lead to the formation of inhibitory antibodies. Patients who develop high levels of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yatuv, Rivka, Robinson, Micah, Dayan-Tarshish, Inbal, Baru, Moshe
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2010
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2939703/
https://ncbi.nlm.nih.gov/pubmed/20856833
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!